Skip to main content
SpringerLink
Log in

Letter to the Editor

  • Letter to the Editor
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCES

  1. Chesnut CH III, Harris ST: Short-term effect of alendronate on bone mass and bone remodeling in postmenopausal women. Osteoporos Int 3(suppl 3):S17–S19, 1993

    Google Scholar 

  2. Maconi G, Porro GB: Multiple ulcerative esophagitis caused by alendronate. Am J Gastroenterol 90:1889–1890, 1995

    Google Scholar 

  3. Abdelmalek MF, Douglas DD: Alendronate-induced ulcerative esophagitis. Am J Gastroenterol 91:1282-1283, 1996 (letter)

    Google Scholar 

  4. Warning about oesophagitis with Fosamax. Lancet 347:959, 1996

  5. Nightinggale SL: From the Food and Drug Administration. JAMA 275:1534, 1996

    Google Scholar 

  6. de Groen PC, Lubbe DF, Hirsch LJ, Daifotis A, Stephenson W, Freedholm D, Pryor-Tillotson S, Seleznick MJ, Pinkas H, Wang KK: Esophagitis associated with the use of alendronate. N Engl J Med 335:1016–1021, 1996

    Google Scholar 

  7. Elliot SN, McKnight W, Davies NM, MacNaughton WK, Wallace JL: Alendronate induces gastric injury and delays ulcer healing in rodents. Life Sci 62:77–91, 1998

    Google Scholar 

  8. Blank MA, Ems BL, Gibson GW, Myers WR, Berman SK, Phipps RJ, Smith PN: Nonclinical model for assessing gastric effects of biphosphonates. Dig Dis Sci 42:281–288, 1997

    Google Scholar 

  9. Graham DY, Malaty HM, Goodgame R: Primary aminobiphosphonate s: A new class of gastrotoxic drugs— comparison of alendronate and aspirin. Am J Gastroenterol 92:1322–1325, 1997

    Google Scholar 

  10. Francis RM: Oral bisphosphonates in the treatment of osteoporosis: A review. Curr Ther Res 56:831–851, 1995

    Google Scholar 

  11. Adami S, Mian M, Gatti P, Rossini M, Zamberlan N, Bertoldo F, Lo Cascio V: Effects of two oral doses of alendronate in the treatment of Paget's disease of bone. Bone 15:415–417, 1994

    Google Scholar 

  12. Graham DY: Effectiveness and tolerance of “solid vs liquid” potassium replacement therapy: Arrhythmias, myocardial infarction, and hypertension. In Potassium in Cardiovascular and Renal Medicine. PK Welton, A Welton, W Gordon Walker (eds). New York, Marcel Dekker, 1986, pp 435–450

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Letter to the Editor. Dig Dis Sci 44, 903–904 (1999). https://doi.org/10.1023/A:1026687925758

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1026687925758

Keywords

Search

Navigation